Yufan Zheng

Yufan Zheng

Auto-generated profile, based on publicly available information

Yufan Zheng

Cleveland Clinic, Cleveland, OH, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2021 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
PDF file
YZYufan Zheng
Yufan Zheng
JDJessica Dudman
Jessica Dudman
JCJacqueline T Chen
Jacqueline T Chen
KMKedar R Mahajan
Kedar R Mahajan
DHDanielle Herman
Danielle Herman
KNKunio Nakamura
Kunio Nakamura
Detecting cortical demyelination using magnetic resonance imaging (MRI) in multiple sclerosis (MS) remains a challenge. Magnetization transfer ratio (MTR), T1-weighted/T2-weighted ratio (T1T2R), and T2-weighted (T2w) signal are sensitive to cortical demyelination, but their accuracy is unknown. To quantify the sensitivity, specificity, and accuracy of postmortem T1T2R, MTR, and T2w in detecting cortical demyelination. In situ postmortem MRIs from 9 patients were used to measure T1T2R, MTR, and T2w along the midline of cortical gray matter and classified as normal or abnormal. MRIs were co-registered and compared to hemispheric myelin staining. The sensitivity, specificity, and accuracy of T1T2R, MTR, and T2w in detecting cortical demyelination were measured. The mean age (standard deviation) at death was 64.7 (+/-13.7) years with a disease duration of 23.8 (+/-10.5) years. The sensitivity was 78% for MTR, 75% for T1T2R, and 63% for T2w. The specificity was 46% (T2w), 13% (T1T2R), and 29% (MTR). The accuracy was 71% (T2w), 39% (MTR), and 42% (T1T2R). There were no significant differences between different MRI measures in cortical demyelination or intracortical/subpial lesion detection. Although somewhat sensitive, the modest specificity of conventional MRI modalities for cortical demyelination indicates that they are influenced by cortical changes other than demyelination. Improved acquisition and post-processing are needed to reliably measure cortical lesion load.

3 August 2023 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
KNKunio Nakamura
Kunio Nakamura
YZYufan Zheng
Yufan Zheng
KMKedar R Mahajan
Kedar R Mahajan
JCJeffrey A Cohen
Jeffrey A Cohen
RFRobert J Fox
Robert J Fox
DODaniel Ontaneda
Daniel Ontaneda
Background: Thalamic volume (TV) is a sensitive biomarker of disease burden of injury in multiple sclerosis (MS) and appears to reflect overall lesion loads. Ibudilast showed significant treatment effect on brain atrophy and magnetization transfer ratio (MTR) of normal-appearing brain tissue but not in new/enlarging T2 lesion in the SPRINT-MS randomized clinical trial. Objective: To evaluate the effect of ibudilast on thalamic tissue integrity and volume in the SPRINT-MS. Methods: A total of 255 participants with progressive MS were randomized to oral ibudilast or placebo, and thalamic MTR and normalized TV over 96 weeks were quantified. Mixed-effect modeling assessed treatment effects on the thalamic MTR and TV, separately. Similarly, the measures were compared between the participants with confirmed disability progression (CDP). Results: Ibudilast’s treatment effect was observed compared to placebo for thalamic MTR ( p = 0.03) but not for TV ( p = 0.68) while TV correlated with T2 lesion volume ( p < 0.001). CDP associated with thalamic MTR ( p = 0.04) but not with TV ( p = 0.7). Conclusion: Ibudilast showed an effect on thalamic MTR, which was associated with CDP, suggesting a clinically relevant effect on thalamic tissue integrity. However, the treatment effect was not observed in TV, suggesting that thalamic atrophy is more closely associated with global inflammatory activity than local tissue integrity. ClinicalTrials.gov: NCT01982942

6 April 2015 in Neurology
Verified
Journal Article
Closed access
YZYufan Zheng
Yufan Zheng
RRRichard Rudick
Richard Rudick
JLJar-Chi Lee
Jar-Chi Lee
EFElizabeth Fisher
Elizabeth Fisher